BioRender
PrivateLast Round
VC Round
Dec 18, 2025
Est. Valuation
$900M
Total Funding Raised
$45.12M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioRender is a software company that provides a science illustration software designed to empower the world to learn and communicate science through visuals.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Content Creation, Data Visualization
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioRender Comparables
Compare BioRender with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cactus Communications | 82% | |
| SciFig | 71% | |
| Illustrae | 71% |
BioRender Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 18, 2025 | ||||
| Series B | Mar 21, 2022 | ||||
| Accelerator | Mar 21, 2018 |
Key People
Founding team and executive leadership
BioRender Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Accelerator |
| TCV | Series B |
| Inovia Capital | Series B |
| Dimension | VC Round |
| Real Ventures | Series B |
| Y Combinator | Series B, Accelerator |
| Dimension | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Job posting discloses that its figures have appeared in more than 54,000 publications.
- Jun 25, 2026
Announced the launch of BioRender Graphing.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
BioRender had revenue of $30.8M on Jun 1st '24.
- has_revenueSep 2, 2026
BioRender had revenue of $36.5M on Dec 1st '24.
BioRender Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioRender's valuation, stock price, and market status.
Is BioRender a public or private company?
BioRender is a private company.
What is the current stock price of BioRender?
BioRender is a private company with no public stock price. No recent secondary market data is available.
How much is BioRender worth (valuation)?
BioRender's valuation is estimated at $900.0M based on funding round data.
Can I buy BioRender stock?
BioRender shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioRender's last funding round?
BioRender's most recent funding round was Growth Equity on December 18, 2025.
Who are the main investors in BioRender?
Key investors in BioRender include TCV, Inovia Capital, Dimension, Y Combinator, Dimension.
Will BioRender IPO soon?
No public IPO plans have been announced for BioRender.
How can I track BioRender secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioRender's secondary market activity and sign up for updates.